HARRISBURG — Two state senators, one a Republican and the other a Democrat, said on Monday they plan to introduce a bill to legalize a certain form of marijuana for medicinal use in Pennsylvania in an effort to help children who suffer seizures and potentially many others, including patients suffering through chemotherapy.
Sens. Daylin Leach, D-Montgomery, and Mike Folmer, R-Lebanon, said their bill would help ensure Pennsylvanians can get medical benefits from cannabidiol, or CBD, a compound found in marijuana that is credited with various medical applications without providing a high.
It is the first time that a medical marijuana bill has been drafted with bipartisan support in the Senate, Leach said.
Under the bill, Pennsylvania doctors would be limited to prescribing medicine derived from marijuana that has a higher amount of CBD than marijuana's psychoactive chemical, known as THC, Leach said.
It would not be addictive or psychoactive, and could be used in place of pharmaceuticals that are toxic, addictive or riddled with side effects, Leach said.
“There is no rational reason not to support giving a child this medication,” Leach told a Capitol news conference packed with supporters of legalizing medical marijuana.
It can be adminstered by dropper for children and in pill form for adults.
Two Pennsylvania mothers of children with epilepsy, including a boy who has a rare and sometimes deadly form called Dravet syndrome, appeared with Leach and said they believe it can control their children's debilitating seizures.
“My plea today to the government is to leave the doctoring to the doctors,” said Dana Ulrich of Reinholds. She said her daughter Lorelei, 6, suffers about 400 seizures a day.
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.